Nucleosome assembly protein 1-like 1 (NAP1L1) in colon cancer patients: a potential biomarker with diagnostic and prognostic utility.

Aydin M. A., Gul G., Kiziltan R., Algul S., Kemik O.

European review for medical and pharmacological sciences, vol.24, no.20, pp.10512-10517, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 24 Issue: 20
  • Publication Date: 2020
  • Doi Number: 10.26355/eurrev_202010_23403
  • Journal Name: European review for medical and pharmacological sciences
  • Journal Indexes: Scopus, EMBASE, MEDLINE, Science Citation Index Expanded (SCI-EXPANDED)
  • Page Numbers: pp.10512-10517
  • Keywords: Colon cancer, NAP1L1, Marker, Early diagnosis, Risk stratification, Stage, Controls, COLORECTAL-CANCER
  • Van Yüzüncü Yıl University Affiliated: Yes

Abstract

OBJECTIVE: To evaluate the diagnostic and prognostic utility of nucleosome assembly protein 1-like 1 (NAP1L1) in colon cancer patients.